2023
DOI: 10.1016/j.heliyon.2023.e22009
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis, in vitro, and in silico evaluations of kojic acid derivatives linked to amino pyridine moiety as potent tyrosinase inhibitors

Davood Rezapour Niri,
Mohammad Hosein Sayahi,
Somayeh Behrouz
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 34 publications
0
0
0
Order By: Relevance
“…Furthermore, the size of the substituent groups and the possibility of the Kojic moiety engaging with both copper ions are also determining factors for occupation of the enzyme binding pocket. 37 The comparison of their results with our data at the same concentration (50 μM) revealed that our synthetic pyridine derivatives showed overal higher inhibitory effects [∼50, 45, 75, 70, and 80% inhibition by compounds 1, 2, 3, 4 and 5, respectively, Figure S4 (Supporting Information)] and the calculated IC 50 values for our most potent inhibiting compounds (3, 4, and 5, with the IC 50 values of 12.0, 17.0, and 9.0 μM, respectively) were less than those from their reported potent inhibitors (compounds 4b, 4d, 4f, and 4h with the IC 50 values of 28, 22, 23, and 20 μM, respectively).…”
Section: Biochemistrymentioning
confidence: 99%
“…Furthermore, the size of the substituent groups and the possibility of the Kojic moiety engaging with both copper ions are also determining factors for occupation of the enzyme binding pocket. 37 The comparison of their results with our data at the same concentration (50 μM) revealed that our synthetic pyridine derivatives showed overal higher inhibitory effects [∼50, 45, 75, 70, and 80% inhibition by compounds 1, 2, 3, 4 and 5, respectively, Figure S4 (Supporting Information)] and the calculated IC 50 values for our most potent inhibiting compounds (3, 4, and 5, with the IC 50 values of 12.0, 17.0, and 9.0 μM, respectively) were less than those from their reported potent inhibitors (compounds 4b, 4d, 4f, and 4h with the IC 50 values of 28, 22, 23, and 20 μM, respectively).…”
Section: Biochemistrymentioning
confidence: 99%